Nanosuspensions accelerate drug substance dissolution rates by increasing surface area and reducing particle size.

The key to nanosuspension development is the identification of a suitable stabiliser system, such that crystal growth and agglomeration effects are suppressed during the lifetime of the formulation.

In addition to a broad range of milling systems, Ardena has technologies to convert (liquid) nanosuspensions into solid forms.